SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-13-000038
Filing Date
2013-05-03
Accepted
2013-05-02 17:49:21
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 640816
2 exhibit10-1.htm EX-10.1 17697
3 exhibit10-2.htm EX-10.2 56488
4 exhibit12.htm EX-12 48104
5 exhibit31-1.htm EX-31 8960
6 exhibit31-2.htm EX-31.2 8963
7 exhibit32-1.htm EX-32.1 3140
8 exhibit32-2.htm EX-32.2 3167
  Complete submission text file 0001367644-13-000038.txt   4336471

Data Files

Seq Description Document Type Size
9 ebs-20130331.xsd EX-101.SCH 30555
10 ebs-20130331_cal.xml EX-101.CAL 59013
11 ebs-20130331_def.xml EX-101.DEF 170069
12 ebs-20130331_lab.xml EX-101.LAB 547494
13 ebs-20130331_pre.xml EX-101.PRE 319327
14 ebs-20130331.xml EX-101.INS 456668
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 13809470
SIC: 2834 Pharmaceutical Preparations